Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.24 USD | +4.33% |
|
+7.96% | +13.96% |
01/07 | Travere Therapeutics, Inc.(NasdaqGM:TVTX) dropped from Russell 3000 Growth Index | CI |
01/07 | Travere Therapeutics, Inc.(NasdaqGM:TVTX) dropped from Russell 3000E Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.96% | 747M | |
+20.30% | 127B | |
+24.25% | 117B | |
+25.44% | 27.67B | |
-18.52% | 20.33B | |
-15.17% | 16.79B | |
-15.91% | 15.63B | |
+12.84% | 14.84B | |
-47.10% | 14.65B | |
+57.29% | 14.43B |
- Stock Market
- Equities
- TVTX Stock
- News Travere Therapeutics, Inc.
- Retrophin, Inc. Provides Preliminary and Unaudited Financial Data for the Fourth Quarter and Full Year of 2016